CUSIP: G6S41R101
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
17,303,008
-
Share change
-
+13,191,495
-
Total reported value
-
$18,657,000
-
Price per share
-
$1.08
-
Number of holders
-
28
-
Value change
-
+$13,947,606
-
Number of buys
-
13
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP G6S41R101:
Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q4 2021
As of 31 Dec 2021,
OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,303,008 shares.
The largest 10 holders included
Athyrium Capital Management, LP, Rovida Advisors Inc., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, Alyeska Investment Group, L.P., ArrowMark Colorado Holdings LLC, TWO SIGMA INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.